| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.028 | 13.043 | 12.221 | 14.145 | 17.457 | 11.474 | 15.650 | 18.143 | 16.975 | 19.782 |
| Total Income - EUR | 8.124 | 15.476 | 14.540 | 16.063 | 19.338 | 14.226 | 17.437 | 20.511 | 18.532 | 19.829 |
| Total Expenses - EUR | 2.751 | 13.305 | 11.362 | 15.855 | 18.879 | 15.232 | 14.816 | 17.089 | 17.378 | 20.217 |
| Gross Profit/Loss - EUR | 5.373 | 2.172 | 3.178 | 208 | 459 | -1.006 | 2.621 | 3.421 | 1.155 | -388 |
| Net Profit/Loss - EUR | 5.166 | 1.986 | 2.898 | 54 | 269 | -1.136 | 2.450 | 3.228 | 972 | -587 |
| Employees | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - City-Derm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.212 | 15.593 | 13.010 | 11.384 | 8.762 | 6.751 | 4.814 | 1.751 | 46 | 0 |
| Current Assets | 6.838 | 8.928 | 11.646 | 10.876 | 10.680 | 10.586 | 11.381 | 1.962 | 1.561 | 1.527 |
| Inventories | 947 | 839 | 2.384 | 3.880 | 2.199 | 1.507 | 355 | 356 | 355 | 353 |
| Receivables | 0 | 41 | 41 | 40 | 39 | 38 | 37 | 38 | 0 | 0 |
| Cash | 5.891 | 8.048 | 9.221 | 6.956 | 8.442 | 9.041 | 10.989 | 1.569 | 1.206 | 1.174 |
| Shareholders Funds | 5.211 | 7.077 | 9.856 | 9.729 | 9.809 | 8.488 | 10.749 | 1.236 | 714 | 123 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 910 | 17.444 | 1.790 | 1.678 | 871 | 2.098 | 631 | 727 | 847 | 1.404 |
| Income in Advance | 18.929 | 15.593 | 13.010 | 10.854 | 8.762 | 6.751 | 4.814 | 1.751 | 46 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - City-Derm S.r.l.